{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:33:39Z","timestamp":1784086419544,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Update"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.tru.2022.100098","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T08:17:19Z","timestamp":1641802639000},"page":"100098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need"],"prefix":"10.1016","volume":"6","author":[{"given":"Benjamin","family":"Brenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Thereza Cavalcanti","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Abdel-Razeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tru.2022.100098_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","article-title":"Venous thromboembolism and prognosis in cancer","volume":"125","author":"Khorana","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.tru.2022.100098_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fcvm.2016.00024","article-title":"Venous thromboembolism in cancer: an update of treatment and prevention in the era of newer anticoagulants","volume":"3","author":"Qureshi","year":"2016","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.tru.2022.100098_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tru.2022.100098_bib4","series-title":"Features, Evaluation and Treatment Coronavirus (COVID-19)","author":"Cascella","year":"2020"},{"key":"10.1016\/j.tru.2022.100098_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of coronavirus disease 2019","author":"Iba","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.tru.2022.100098_bib6","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.tru.2022.100098_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00414-020-02317-w","article-title":"Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany","volume":"134","author":"Edler","year":"2020","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.tru.2022.100098_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.tru.2022.100098_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15294","article-title":"Similarities and perspectives on the two C's - cancer and COVID-19","author":"Thachil","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.tru.2022.100098_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jjcc.2018.02.011","article-title":"Mechanism and management of cancer-associated thrombosis","volume":"72","author":"Mukai","year":"2018","journal-title":"J. Cardiol."},{"issue":"1","key":"10.1016\/j.tru.2022.100098_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.tru.2022.100098_bib12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1055\/s-0040-1714275","article-title":"Thrombosis and hemostasis issues in cancer patients with COVID-19","volume":"46","author":"Horowitz","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"issue":"10","key":"10.1016\/j.tru.2022.100098_bib13","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/jth.15463","article-title":"The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19","volume":"19","author":"Li","year":"2021","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.tru.2022.100098_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15018","article-title":"Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19","author":"Patell","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"issue":"1","key":"10.1016\/j.tru.2022.100098_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkaa085","article-title":"Clinical course of cancer patients with COVID-19: a retrospective cohort study","volume":"5","author":"Alpert","year":"2021","journal-title":"JNCI Cancer Spectr."},{"issue":"15_suppl","key":"10.1016\/j.tru.2022.100098_bib16","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1200\/JCO.2021.39.15_suppl.2627","article-title":"Association and prevalence of venous thromboembolism in cancer patients with COVID-19: A single healthcare system experience","volume":"39","author":"Ananthula","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tru.2022.100098_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3332\/ecancer.2020.1047","article-title":"Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis","volume":"14","author":"Ofori-Asenso","year":"2020","journal-title":"Ecancermedicalscience"},{"issue":"10","key":"10.1016\/j.tru.2022.100098_bib18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S1470-2045(20)30442-3","article-title":"COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study","volume":"21","author":"Lee","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.tru.2022.100098_bib19","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol"},{"issue":"9","key":"10.1016\/j.tru.2022.100098_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12032-020-01406-5","article-title":"COVID-19 and cancer care: what do international guidelines say?","volume":"37","author":"Tartarone","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.tru.2022.100098_bib21","first-page":"w20247","article-title":"Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis","volume":"150","author":"Casini","year":"2020","journal-title":"Swiss Med. Wkly."},{"issue":"1","key":"10.1016\/j.tru.2022.100098_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"Barnes","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.tru.2022.100098_bib23","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020201629","article-title":"Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the national institute for public health of The Netherlands","author":"Oudkerk","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.tru.2022.100098_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.recesp.2020.04.006","article-title":"Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the working group on cardiovascular thrombosis of the Spanish society of cardiology","author":"Vivas","year":"2020","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.tru.2022.100098_bib25","series-title":"Clinical Management of COVID-19","year":"2020"},{"key":"10.1016\/j.tru.2022.100098_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2020.09.009","article-title":"Evidence-based management of COVID-19 in cancer patients: guideline by the infectious diseases working party (AGIHO) of the German society for Haematology and medical Oncology (DGHO)","volume":"140","author":"Giesen","year":"2020","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.tru.2022.100098_bib27","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect. Dis"},{"key":"10.1016\/j.tru.2022.100098_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejim.2020.05.002","article-title":"Bleeding in COVID-19 severe pneumonia: the other side of abnormal coagulation pattern?","volume":"77","author":"Conti","year":"2020","journal-title":"Eur. J. Intern. Med."}],"container-title":["Thrombosis Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666572722000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666572722000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:38:25Z","timestamp":1740890305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666572722000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S2666572722000025"],"URL":"https:\/\/doi.org\/10.1016\/j.tru.2022.100098","relation":{},"ISSN":["2666-5727"],"issn-type":[{"value":"2666-5727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Update","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tru.2022.100098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100098"}}